Logos Global Management Lp Verve Therapeutics, Inc. (VERV) insider trading activity

Logos Global Management LP is > 10% Shareholder of Verve Therapeutics, Inc.. Currently has a direct ownership of 370,000 shares of VERV, which is worth approximately $1.7 Million. The most recent transaction as insider was on Jun 21, 2021, when has been sold 370,000 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $7,030,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 370K

0% 3M change

0% 12M change

Total Value Held $1.7 Million

Logos Global Management LP Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 21 2021	BUY Open market or private purchase	$7,030,000 $19.0 p/Share	370,000 Added 50.0%	370,000 Common Stock

Also insider at

DYN

Dyne Therapeutics, Inc. Healthcare

> 10% Shareholder

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

LGM